Assignment of Downfield Proton Resonances in Purine Nucleoside Phosphorylase·Immucillin-H Complex by Saturation-Transferred NOEs

Biochemistry

Volumn 43, Issue 7, 2004, Pages 1980-1987

  Deng, Hua ^a   Lewandowicz, Andrzej ^a   Cahill, Sean M ^a   Furneaux, Richard H ^b   Tyler, Peter C ^b   Girvin, Mark E ^a   Callender, Robert H ^a   Schramm, Vern L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CALLAGHAN INNOVATION   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; CATALYSIS; CRYSTAL STRUCTURE; ENZYMES; HYDROGEN BONDS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RESONANCE;

BINDING AFFINITY; TRANSITION STATES;

BIOCHEMISTRY;

IMMUCILIN H; PHOSPHATE; PROTEIN; PURINE NUCLEOSIDE PHOSPHORYLASE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENERGY; HUMAN; HYDROGEN BOND; ISOTOPE LABELING; NITROGEN NUCLEAR MAGNETIC RESONANCE; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL;

BINDING, COMPETITIVE; CATALYSIS; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; HYDROGEN BONDING; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN BINDING; PROTONS; PURINE-NUCLEOSIDE PHOSPHORYLASE; PYRIMIDINONES; PYRROLES; RECOMBINANT PROTEINS; SOLUTIONS; THERMODYNAMICS;

EID: 1242285470     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0358115     Document Type: Article

References (40)

1. Stoeckler, J. D. (1984) in Developments in Cancer Chemotherapy (Glazer, R. J., Ed.) pp 35-60, CRC Press Inc., Boca Raton, FL.
2. Bzowska, A., Kulikowska, E., and Shugar, D. (2000) Purine nucleoside phosphorylases: properties, functions, and clinical aspects, Pharmacology Ther. 88, 349-425.
3. Fedorov, A., Shi, W., Kicska, G., Fedorov, E., Tyler, P. C., Furneaux, R. H., Hanson, J. C., Gainsford, G. J., Larese, J. Z., Schramm, V. L., and Almo, S. C. (2001) Transition state structure of purine nucleoside phosphorylase and principles of atomic motion in enzymatic catalysis, Biochemistry 40, 853-60.
4. Miles, R. W., Tyler, P. C., Furneaux, R. H., Bagdassarian, C. K., and Schramm, V. L. (1998) One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase, Biochemistry 37, 8615-21.
5. Kicska, G. A., Tyler, P. C., Evans, G. B., Furneaux, R. H., Schramm, V. L., and Kim, K. (2002) Purine-less death in Plasmodium falciparum induced by immucillin-H, a transition state analogue of purine nucleoside phosphorylase, J. Biol. Chem. 277, 3226-31.
6. Kicska, G. A., Tyler, P. C., Evans, G. B., Furneaux, R. H., Kim, K., and Schramm, V. L. (2002) Transition state analogue inhibitors of purine nucleoside phosphorylase from Plasmodium falciparum, J. Biol. Chem. 277, 3219-25.
7. Li, C. M., Tyler, P. C., Furneaux, R. H., Kicska, G., Xu, Y., Grubmeyer, C., Girvin, M. E., and Schramm, V. L. (1999) Transition-state analogs as inhibitors of human and malarial hypoxanthine-guanine phosphoribosyltransferases, Nat. Struct. Biol. 6, 582-7.
8. Shi, W., Li, C. M., Tyler, P. C., Furneaux, R. H., Cahill, S. M., Girvin, M. E., Grubmeyer, C., Schramm, V. L., and Almo, S. C. (1999) The 2.0 A structure of malarial purine phosphoribosyltransferase in complex with a transition-state analogue inhibitor, Biochemistry 38, 9872-80.
9. Shi, W., Li, C. M., Tyler, P. C., Furneaux, R. H., Grubmeyer, C., Schramm, V. L., and Almo, S. C. (1999) The 2.0 A structure of human hypoxanthine-guanine phosphoribosyltransferase in complex with a transition-state analog inhibitor, Nat. Struct. Biol. 6, 588-93.
10. Sauve, A. A., Cahill, S. M., Zech, S. G., Basso, L. A., Lewandowicz, A., Santos, D. S., Grubmeyer, C., Evans, G. B., Furneaux, R. H., Tyler, P. C., McDermott, A., Girvin, M. E., and Schramm, V. L. (2003) Ionic states of substrates and transition state analogues at the catalytic sites of N-ribosyltransferases. Biochemistry 42, 5694-705.
11. Kicska, G. A., Tyler, P. C., Evans, G. B., Furneaux, R. H., Shi, W., Fedorov, A., Lewandowicz, A., Cahill, S. M., Almo, S. C., and Schramm, V. L. (2002) Atomic dissection of the hydrogen bond network for transition-state analogue binding to purine nucleoside phosphorylase, Biochemistry 41, 14489-98.
12. Lin, J., Westler, W. M., Cleland, W. W., Markley, J. L., and Frey, P. A. (1998) Fractionation factors and activation energies for exchange of the low barrier hydrogen bonding proton in peptidyl trifluoromethyl ketone complexes of chymotrypsin, Proc. Natl. Acad. Sci. U.S.A. 95, 14664-8.
13. Frey, P. A., Whitt, S. A., and Tobin, J. B. (1994) A low-barrier hydrogen bond in the catalytic triad of serine proteases, Science 264, 1927-30 (comment).
14. Markley, J. L., and Westler, W. M. (1996) Protonation-state dependence of hydrogen bond strengths and exchange rates in a serine protease catalytic triad: bovine chymotrypsinogen A, Biochemistry 35, 11092-7.
15. Gerlt, J. A., Kreevoy, M. M., Cleland, W., and Frey, P. A. (1997) Understanding enzymic catalysis: the importance of short, strong hydrogen bonds, Chem. Biol. 4, 259-67.
16. Mildvan, A. S., Harris, T. K., and Abeygunawardana, C. (1999) Nuclear magnetic resonance methods for the detection and study of low-barrier hydrogen bonds on enzymes, Methods Enzymol. 308, 219-45.
17. Halkides, C. J., Wu, Y. Q., and Murray, C. J. (1996) A low-barrier hydrogen bond in subtilisin: 1H and 15N NMR studies with peptidyl trifluoromethyl ketones. Biochemistry 35, 15941-8.
18. Harris, T. K., Abeygunawardana, C., and Mildvan, A. S. (1997) NMR studies of the role of hydrogen bonding in the mechanism of triosephosphate isomerase, Biochemistry 36, 14661-75.
19. Zhao, Q., Abeygunawardana, C., Gittis, A. G., and Mildvan, A. S. (1997) Hydrogen bonding at the active site of delta 5-3-ketosteroid isomerase, Biochemistry 36, 14616-26.
20. Kintanar, A., Metzler, C. M., Metzler, D. E., and Scott, R. D. (1991) NMR observation of exchangeable protons of pyridoxal phosphate and histidine residues in cytosolic aspartate aminotransferase, J. Biol. Chem. 266, 17222-9.
21. Metzler, D. E., Metzler, C. M., Mollova, E. T., Scott, R. D., Tanase. S., Kogo, K., Higaki, T., and Morino, Y. (1994) NMR studies of 1H resonances in the 10-18-ppm range for cytosolic aspartate aminotransferase. J. Biol. Chem. 269, 28017-26.
22. Erion, M. D., Takabayashi, K., Smith, H. B., Kessi, J., Wagner, S., Honger, S., Shames, S. L., and Ealick, S. E. (1997) Purine nucleoside phosphorylase. 1. Structure-function studies, Biochemistry 36, 11725-34.
23. Stoeckler, J. D., Poirot, A. F., Smith, R. M., Parks, R. E., Jr., Ealick, S. E., Takabayashi, K., and Erion, M. D. (1997) Purine nucleoside phosphorylase. 3. Reversal of purine base specificity by site-directed mutagenesis, Biochemistry 36, 11749-56.
24. Evans, G. B., Furneaux, R. H., Gainsford, G. J., Hanson, J. C., Kicska, G. A., Sauve, A. A., Schramm, V. L., and Tyler, P. C. (2003) 8-Aza-immucillins as transition-state analogue inhibitors of purine nucleoside phosphorylase and nucleoside hydrolases, J. Med. Chem. 46, 155-60.
25. Evans, G. B., Furneaux, R. H., Hutchison, T. L., Kezar, H. S., Morris, P. E., Jr., Schramm, V. L., and Tyler, P. C. (2001) Addition of lithiated 9-deazapurine derivatives to a carbohydrate cyclic imine: convergent synthesis of the aza-C-nucleoside immucillins, J. Org. Chem. 66, 5723-30.
26. 1H Overhauser Effects in the presence of spin diffusion, J. Magn. Reson. 33, 675-680.
27. Clore, G. M., and Gronenborn, A. M. (1982) Theory and application of the transferred nuclear overhauser effect to the study of the conformations of small ligands bound to proteins, J. Magn. Reson. 48, 402-417.
28. Haselhorst, T., Espinosa, J. F., Jimenez-Barbero, J., Sokolowski, T., Kosma, P., Brade, H., Brade, L., and Peters, T. (1999) NMR experiments reveal distinct antibody-bound conformations of a synthetic disaccharide representing a general structural element of bacterial lipopolysaccharide epitopes, Biochemistry 38, 6449-59.
29. Mayer, M., and Meyer, B. (1999) Characterization of ligand binding by saturation transfer difference NMR spectroscopy, Angew. Chem. Int. Ed. 38, 1784-1788.
30. Hwang, T. L., and Shaka, A. J. (1995) Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulsed-field gradients, J. Magn. Reson., A 112, 275-279.
31. Wang, F., Miles, R. W., Kicska, G., Nieves, E., Schramm, V. L., and Angeletti, R. H. (2000) Immucillin-H binding to purine nucleoside phosphorylase reduces dynamic solvent exchange, Protein Sci. 9, 1660-8.
32. Kline, P. C., and Schramm, V. L. (1993) Purine nucleoside phosphorylase. Catalytic mechanism and transition-state analysis of the arsenolysis reaction, Biochemistry 32, 13212-9.
33. Kline, P. C., and Schramm, V. L. (1995) Pre-steady-state transition-state analysis of the hydrolytic reaction catalyzed by purine nucleoside phosphorylase, Biochemistry 34, 1153-62.
34. Schramm, V. L., and Shi, W. (2001) Atomic motion in enzymatic reaction coordinates, Curr. Opin. Struct. Biol. 11, 657-65.
35. Wei, Y., and McDermott, A. E. (1999) in Modeling NMR Chemical Shifts: gaining insights into structure and environment (Facelli, J. C., and deDios, A. C., Eds.) pp 177-193, Oxford University Press, Oxford, U.K.
36. Neal, S., Nip, A. M., Zhang, H., and Wishart, D. S. (2003) Rapid and accurate calculation of protein 1H, 13C and 15N chemical shifts, J. Biomol. NMR 26, 215-40.
37. Johnson, C. E., and Bovey, F. A. (1958) Calculation of nuclear magnetic resonance spectra of aromatic hydrocarbon, J. Chem. Phys. 29, 1012-1014.
38. Loh, S. N., and Markley, J. L. (1994) Hydrogen bonding in proteins as studied by amide hydrogen D/H fractionation factors: application to staphylococcal nuclease, Biochemistry 33, 1029-36.
39. Kreevoy, M. M., and Liang, T. M. (1980) Structures and isotopic fractionation factors of complexes, A1HA2-, J. Am. Chem. Soc. 102, 3315-3322.
40. Mazumder, D., Kahn, K., and Bruice, T. C. (2002) Computer simulations of trypanosomal nucleoside hydrolase: determination of the protonation state of the bound transition-state analogue, J. Am. Chem. Soc. 124, 8825-33.